Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

To determine if Tetrix Cream, when applied to the skin lesions on patients with contact dermatitis, improves the symptoms of burning and itching.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contact Dermatitis Dermatitis Dermatitis, Contact Pathological Conditions, Signs and Symptoms Pruritus Signs and Symptoms Skin Diseases Skin Diseases, Eczematous Skin Manifestations Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dermatology Specialists, LLC

Louisville, Kentucky, 40202, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Normal subjects with sensitivity to nickel
Subjects with hand eczema

Exclusion criteria

under 18 years of age

Treatment and study plan

Tetrix

Device

Twice daily topical application

PLACEBO

Device

Twice daily topical application

Primary outcomes

Improvement in symptoms of burning and itching.

Time frame: after 14 days of treatment

Sponsors and collaborators

Lead sponsor

Coria Laboratories, Ltd.

Industry

Registry information

Official study title

An Open Label Study of the Therapeutic Effects of Tetrix Cream in Allergic Contact and Irritant Contact Dermatitis

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Mar 31, 2008
Registry last updated: May 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed